← Back to Clinical Trials
Recruiting NCT07935473

NCT07935473 Effects of "Exercise Snack" in Individuals With Obesity

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07935473
Status Recruiting
Phase —
Sponsor Istituto Auxologico Italiano
Condition Obesity & Overweight
Study Type INTERVENTIONAL
Enrollment 8 participants
Start Date 2026-11-01
Primary Completion 2027-02-25

Eligibility & Interventions

Sex All sexes
Min Age 30 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
Exercise snackConventional exercise training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 8 participants in total. It began in 2026-11-01 with a primary completion date of 2027-02-25.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Obesity is associated with reduced physical fitness, functional limitations, and poorer quality of life (Kell et al., 2001). Nutritional support and supervised exercise can improve weight management and physical health, but low motivation and perceived lack of time often limit participation to physical activity (Alberga et al., 2013; Baillot et al., 2021). Evidence shows that shorter-time exercise strategies may help overcome these barriers and support training adherence (Poon et al., 2020). Brief activity bouts distributed throughout the day, including vigorous intermittent lifestyle physical activity and structured "exercise snacks," may help to improve cardiorespiratory fitness, muscle function, and metabolic health (Islam et al., 2022; Ahmadi et al., 2024; Wang et al., 2024). Observational evidence also links VILPA to lower mortality risk (Stamatakis et al., 2023). Combining brief exercise bouts with education to interrupt prolonged sitting may therefore address both insufficient physical activity and sedentary behaviour (Dunstan et al., 2021; Dogra et al., 2022; Pinto et al., 2023). Generally, research has largely focused on healthy, inactive adults, with limited evidence in people with overweight or obesity (Jones et al., 2024). Rafiei et al. (2021) reported acute improvements in insulin and non-esterified fatty acid responses following brief stair-climbing bouts compared with prolonged sitting in adults with obesity. Schmidt et al. (2001) found comparable improvements in body composition and aerobic fitness following accumulated or continuous exercise during caloric restriction. The effects of exercise snacks combined with education to reduce sedentary behaviour nevertheless remain unclear. This study aims to evaluate the effects of an exercise-snacking programme on body composition, physical fitness, quality of life, and exercise adherence in adults with obesity.

Eligibility Criteria

Inclusion Criteria: * Male or female gender * Body Mass Index more than 30 kg/m2 * Participation in physical activity fewer than twice per week * informed consent signature Exclusion Criteria: * aged more than 70 years * history of disabling musculoskeletal or osteoarticular conditions that prevent regular participation in physical activity, with a pain score \> of 7 out of 10 arbitrary units on the visual analogue scale (VAS) * history of hip or knee replacement * Surgery within the 6 months preceding the study * presence of severe hip or knee osteoarthrosis * presence of cardiac, neurological or psychiatric disordes

Contact & Investigator

Central Contact

Luca Cavaggioni, PhD

✉ cavaggioni.luca@gmail.com

📞 +3902619111

Principal Investigator

Luca Cavaggioni, PhD

PRINCIPAL INVESTIGATOR

Istituto Auxologico Italiano IRCCS

Frequently Asked Questions

Who can join the NCT07935473 clinical trial?

This trial is open to participants of all sexes, aged 30 Years or older, up to 70 Years, studying Obesity & Overweight. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07935473 currently recruiting?

Yes, NCT07935473 is actively recruiting participants. Contact the research team at cavaggioni.luca@gmail.com for enrollment information.

Where is the NCT07935473 trial being conducted?

This trial is being conducted at Milan, Italy.

Who is sponsoring the NCT07935473 clinical trial?

NCT07935473 is sponsored by Istituto Auxologico Italiano. The principal investigator is Luca Cavaggioni, PhD at Istituto Auxologico Italiano IRCCS. The trial plans to enroll 8 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology